Real-World Evidence Circles

Can you trace the journey of your code with confidence?

In today’s complex software ecosystems, code moves across multiple teams, tools, and environments. Without a clear chain of custody, organizations risk losing visibility, trust, and control.

A structured, end-to-end trail of code ownership and handling isn’t just a security measure — it’s becoming a business imperative.

Discover in the article why leading organizations are prioritizing code provenance and how it can strengthen your software supply chain: https://hubs.li/Q04mgyc_0

The Chain of Custody for Code | RegenMed Why AI needs a chain of custody—from data to deployment—to ensure accountability, transparency, and trust in healthcare decision-making.

Is your revenue cycle still being treated as a back-office function — or as a strategic growth driver?

Leading healthcare organizations are redefining their approach by turning data collection into a powerful profit center. In this expert perspective, we explore how smarter data strategies can unlock hidden revenue, reduce inefficiencies, and drive more informed decision-making across the entire revenue cycle.

From optimizing front-end data capture to leveraging analytics for financial performance, the discussion highlights practical steps providers can take to transform their operations and strengthen long-term sustainability.

If you’re looking to elevate your revenue cycle beyond traditional boundaries, this is a conversation worth exploring.

Read the full article below to gain deeper insights:

Revenue Cycle Transformation: Converting Data Collection into a Profit Center | RegenMed Transform healthcare data into a profit center. Discover how Split-IP ownership and automated CMS compliance convert data collection into revenue.

The latest MOTIV™ TKA Circle Hour delivered a clear signal: this initiative is gaining real traction — and fast.

In just a few months:

• ~200 patients enrolled
• Exceptional patient engagement
• Strong early recovery outcomes

But what matters most is how these insights are being generated — live, collaboratively, and in real time during discussions.

This is a new model for clinical progress: faster than traditional research, grounded in , and driven directly by physicians.

We’re just getting started.

Learn more: https://www.rgnmed.com/motiv

Bridging the gap between research and real-world impact is no longer optional — it’s essential.
In our latest article, we explore how embedding science directly into practice is transforming healthcare delivery, enabling smarter decisions, better outcomes, and sustainable innovation. Discover how leading organizations are turning evidence into action:

Embedding Science in Practice | RegenMed How embedding research into routine care creates continuous, real-time evidence generation—turning healthcare into a learning system by design.

The “middle” in is disappearing — and it’s reshaping how evidence is generated.

What happens when the space for practical, fast-moving studies is gone?

Explore what this means for providers and researchers:

The Vanishing Middle | RegenMed Why small, hypothesis-driven clinical studies disappeared—and how rebuilding the research middle tier could accelerate medical progress.

𝐓𝐨𝐝𝐚𝐲: 𝐓𝐡𝐞 𝐁𝐞𝐠𝐢𝐧𝐧𝐢𝐧𝐠 𝐨𝐟 𝐭𝐡𝐞 𝐏𝐨𝐬𝐭-𝐎𝐩 𝐒𝐡𝐢𝐟𝐭?

We’re still prescribing opioids after orthopedic surgery — but hashtag 𝐦𝐚𝐲 𝐛𝐞 𝐩𝐨𝐢𝐧𝐭𝐢𝐧𝐠 𝐢𝐧 𝐚 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐝𝐢𝐫𝐞𝐜𝐭𝐢𝐨𝐧.

Tonight, we’ll share early insights from 𝟏𝟗𝟎+ 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 on:

• Opioid utilization
• Non-opioid strategies
• Real-world recovery patterns
This isn’t theoretical — it’s 𝐞𝐚𝐫𝐥𝐲 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐬𝐢𝐠𝐧𝐚𝐥 𝐟𝐫𝐨𝐦 𝐫𝐞𝐚𝐥 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬.

⏳ Starting at 7 PM EDT.

𝐁𝐞 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧: 5b3024fd-4131-45b0-8ac9-7a3664feaa1a@0acc83c6-de26-476b-acb8-fdd58b263b94" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/5b3024fd-4131-45b0-8ac9-7a3664feaa1a@0acc83c6-de26-476b-acb8-fdd58b263b94

What if we’ve been treating the 𝘸𝘳𝘰𝘯𝘨 𝘱𝘳𝘰𝘣𝘭𝘦𝘮 all along?

For years, cardiovascular, kidney, and metabolic diseases have been managed in silos — despite being deeply interconnected. Today, the 𝐂𝐊𝐌 𝐦𝐨𝐝𝐞𝐥 is challenging that approach, reframing multi-comorbid care as a single, system-level problem.

But here’s where it gets critical for providers and researchers: this shift isn’t just clinical — it’s economic. With value-based frameworks accelerating, success now depends on the ability to 𝐜𝐨𝐨𝐫𝐝𝐢𝐧𝐚𝐭𝐞 𝐜𝐚𝐫𝐞, 𝐦𝐞𝐚𝐬𝐮𝐫𝐞 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬, 𝐚𝐧𝐝 𝐢𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐞 𝐞𝐚𝐫𝐥𝐢𝐞𝐫 𝐚𝐜𝐫𝐨𝐬𝐬 𝐭𝐡𝐞 𝐞𝐧𝐭𝐢𝐫𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐮𝐦.

From an expert lens, this raises urgent questions:
• How do we break down specialty silos in real-world practice?
• What capabilities are required to manage CKM as an integrated system?
• And who is best positioned to lead this transformation?

Organizations that answer these questions first won’t just adapt — they’ll lead.

Dive into the full perspective below and see what this means for the future of care: https://hubs.li/Q04lppyB0

CKM Integration: Managing the Multi-Comorbid Patient in a Value-Based World | RegenMed Integrated CKM care under CMS ACCESS ties revenue to blood pressure, eGFR, and metabolic control—driving value-based performance and risk reduction.

Healthcare is entering its next accountability era.

The question is no longer what happened — it’s how we respond at scale.
As the continues to reshape regulation, reimbursement, and public expectations, health systems are being asked to demonstrate measurable progress in and safer care delivery.

The MOTIV™ TKA Protocol enables orthopedic service lines to operationalize this shift — supporting standardized, opioid‑sparing perioperative pathways for total knee arthroplasty while aligning with state-level opioid abatement strategies and funding frameworks.

For enterprise organizations, this is about more than protocol adoption:

➡️ Advancing system-wide consistency in surgical care
➡️ Strengthening alignment with public-health mandates
➡️ Positioning orthopedic programs as leaders in responsible innovation

Accountability is now a performance metric.

Ready to turn opioid accountability into measurable performance? Let’s start the conversation.

Surgical delays are no longer just operational challenges — they’re becoming enterprise-wide risks impacting reimbursement, compliance, and patient outcomes. As new performance-based mandates raise the bar, healthcare leaders must move beyond retrospective reporting and adopt real-time, evidence-driven strategies.

Discover how “surgical-delay proofing” is reshaping clinical and financial performance — and what it takes to stay ahead in a value-based care environment:

The "Surgical-Delay Proof" Record: Justifying Conservative MSK Management | RegenMed Use sensor-based rehab and PROM data to justify conservative MSK care, reduce premature joint surgery, and protect employer health plan margins.